These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 29520101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
    Rawal BD, Cottis L.
    Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
    [Abstract] [Full Text] [Related]

  • 4. A correlation with type of sulfonamide resistance gene in Escherichia coli and synergy between trimethoprim and sulfamethoxazole.
    Valentine CR, Hawk JM, Christian MM, Youmans RW.
    J Basic Microbiol; 1992; 32(3):201-7. PubMed ID: 1512711
    [Abstract] [Full Text] [Related]

  • 5. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.
    Mehta H, Weng J, Prater A, Elworth RAL, Han X, Shamoo Y.
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686152
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
    Ramesh Kumar MR, Arunagirinathan N, Srivani S, Dhanasezhian A, Vijaykanth N, Manikandan N, Balakrishnan S, Vignesh R, Balakrishnan P, Solomon S, Solomon SS.
    Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM, Alejandria M, Henson KE, Alfaraz L, Ata RM, Lopez M, Saniel M.
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tuberculosis and trimethoprim-sulfamethoxazole.
    Forgacs P, Wengenack NL, Hall L, Zimmerman SK, Silverman ML, Roberts GD.
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4789-93. PubMed ID: 19564358
    [Abstract] [Full Text] [Related]

  • 12. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
    Close SJ, McBurney CR, Garvin CG, Chen DC, Martin SJ.
    Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
    [Abstract] [Full Text] [Related]

  • 13. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L, Le Page S, Olaitan AO, Dubourg G, Hadjadj L, Rolain JM.
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decomposition of sulfamethoxazole and trimethoprim by continuous UVA/LED/TiO2 photocatalysis: Decomposition pathways, residual antibacterial activity and toxicity.
    Cai Q, Hu J.
    J Hazard Mater; 2017 Feb 05; 323(Pt A):527-536. PubMed ID: 27324695
    [Abstract] [Full Text] [Related]

  • 19. Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men.
    Witt JM, Koo JM, Danielson BD.
    Ann Pharmacother; 1996 Apr 05; 30(4):347-50. PubMed ID: 8729886
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial synergism in the therapy of experimental cerebral nocardiosis.
    Gombert ME, duBouchet L, Aulicino TM, Berkowitz LB.
    J Antimicrob Chemother; 1989 Jul 05; 24(1):39-43. PubMed ID: 2674100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.